OrbusNeich's cardiology products:
This article was originally published in Clinica
OrbusNeich has gained European go-ahead for three interventional cardiology products: the Blazer cobalt chromium stent, the Sapphire PTCA dilatation catheter and the Lumina 6F guiding catheter. Blazer comprises a dual helix design and thin stent struts, which enable physicians to "overcome the flexibility challenges associated with the slotted tube construction of most stents", claimed the firm, which is headquartered in Hong Kong.
You may also be interested in...
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.